Semaglutide, primarily used for type 2 diabetes treatment, has shown significant results in weight loss
If you notice changes to your period after starting any weight loss medication, it is worth discussing this with your GP or prescribing clinician, as it may indicate a need to review your treatment plan
It was MHRA-approved on 11 June 2026 but has not yet launched commercially
Comparison between China and Europe and WHO-GMP Semaglutide Injection Manufacturer in India WHO-GMP Semaglutide Injection Manufacturer in India Indias pharmaceutical ecosystem, strengthened by every WHO-GMP semaglutide injection manufacturer in India , offers a rare combination of affordability, strict compliance, and largescale production capacity
Sesame Care does offer a lot more flexibility and convenience than many companies
Both contain semaglutide and produce similar weight loss results